- Home
- DERM vs DYOR Comparison
DERM vs DYOR Comparison
Compare DERM & DYOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.79
Company Overview
Basic Information| Metric | DERM | DYOR |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 227.7M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DERM | DYOR |
|---|---|---|
| Price | $7.79 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 192.8K | 40.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,399,000.00 | N/A |
| Revenue This Year | $18.34 | N/A |
| Revenue Next Year | $54.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $3.54 | $10.03 |
| 52 Week High | $9.40 | $10.19 |
Technical Indicators
Market Signals| Indicator | DERM | DYOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | N/A |
| Support Level | $7.52 | N/A |
| Resistance Level | $8.53 | N/A |
| Average True Range (ATR) | 0.42 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 40.48 | 0.00 |
Price Performance
Historical Comparison DERM
DYOR
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About DYOR Insight Digital Partners II Class A Ordinary Shares
Insight Digital Partners II is a blank check company.